Skin melanoma in Italy: a population-based study on survival and prognostic factors

被引:19
|
作者
Balzi, D
Carli, P
Giannotti, B
Buiatti, E
机构
[1] Azienda Osped Careggi, Registro Tumori Toscano, UO Epidemiol, I-50135 Firenze, Italy
[2] Univ Florence, Ist Clin Dermosifilopat, I-50121 Florence, Italy
[3] Ctr Documentaz Salute, I-40100 Bologna, Italy
关键词
survival; melanoma;
D O I
10.1016/S0959-8049(97)10119-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Survival and prognostic factors of invasive cutaneous melanoma patients diagnosed in the province of Florence, Italy, were studied using a regression analysis of relative survival rates. The case series consisted of 428 patients reported by the Tuscany Cancer Registry between 1985 and 1989. The effect of gender, age, anatomical site, histological type and microstaging parameters upon relative survival were evaluated using an extension of the Cox proportional hazard model. Five-year relative survival was 70%; 8-year relative survival, referring to a subset of patients, was 67%. In univariate analysis, the following variables were significantly associated with better prognosis: female gender, age younger than 60 years, superficial spreading melanoma (SSM) compared with nodular melanoma (NIM), location on the Limbs, a thinner lesion according to Breslow, a shallower Clark level. Females had a clear-cut prognostic advantage over males in each category of the variables considered above. After simultaneous adjustment for all other variables, three factors continued to show an independent prognostic effect: age, gender and microstaging parameters (Breslow thickness and Clark level, separately fitted in the model). In the multivariate analysis, the prognostic advantage of females over males was specifically seen for lesions located on the trunk and for both SSM and NIM histotype. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:699 / 704
页数:6
相关论文
共 50 条
  • [21] Diagnostic and prognostic risk factors analysis for distant metastasis in melanoma: a population-based study
    Sun, Junwei
    Wang, Mingyu
    Kan, Zhisheng
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2024, 33 (05) : 461 - 474
  • [23] Population-Based Prognostic Factors for Survival in Patients With Burkitt Lymphoma
    Castillo, Jorge J.
    Winer, Eric S.
    Olszewski, Adam J.
    CANCER, 2013, 119 (20) : 3672 - 3679
  • [24] Prognostic factors for survival in malignant melanoma of the eyelid skin
    Esmaeli, B
    Wang, B
    Deavers, M
    Gillenwater, A
    Goepfert, H
    Diaz, E
    Eicher, S
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2000, 16 (04): : 250 - 257
  • [25] Prognostic factors and survival prediction for patients with metastatic lung adenocarcinoma: A population-based study
    Wu, Bo
    Chen, Jianhui
    Zhang, Xiang
    Feng, Nan
    Xiang, Zhongtian
    Wei, Yiping
    Xie, Junping
    Zhang, Wenxiong
    MEDICINE, 2022, 101 (49) : E32217
  • [26] Survival and Analysis of Prognostic Factors for Bladder Malignancies in Children and Adolescents: A Population-based Study
    Feng, Shaoguang
    Yang, Yicheng
    Yu, Zhechen
    Xiong, Qianwei
    Bi, Yunli
    UROLOGY, 2023, 177 : 156 - 161
  • [27] Survival trends and prognostic factors in patients with solitary plasmacytoma of bone: A population-based study
    Shen, Xuxing
    Liu, Shu
    Wu, Chao
    Wang, Jing
    Li, Jianyong
    Chen, Lijuan
    CANCER MEDICINE, 2021, 10 (02): : 462 - 470
  • [28] Prognostic factors, treatment, and survival in dermatofibrosarcoma protuberans: A population-based cohort study.
    Criscito, Maressa C.
    Martires, Kathryn J.
    Stein, Jennifer A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] Prognostic Factors and Survival in Primary Central Nervous System Lymphoma: A Population-Based Study
    Shan, Yudong
    Hu, Yilan
    DISEASE MARKERS, 2018, 2018
  • [30] Population-based study of breast cancer survival in Cote d'Or (France): prognostic factors and relative survival
    Dabakuyo, T. S.
    Bonnetain, F.
    Roignot, P.
    Poillot, M. -L.
    Chaplain, G.
    Altwegg, T.
    Hedelin, G.
    Arveux, P.
    ANNALS OF ONCOLOGY, 2008, 19 (02) : 276 - 283